Pathways Mediating Impaired Postural Control in Parkinson's Disease
University of Minnesota · NCT06464029
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 160
- US sites recruiting
- 1
- Study start
- June 1, 2024
- Record last updated
- July 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this project is to use transcranial magnetic stimulation (TMS) to explore the state of excitability of corticocortical and corticofugal (cortex to spinal cord, cortex to brainstem to spinal cord) pathways that project to muscles that control the legs and trunk in people with Parkinson's disease. The outcome variables will be further analyzed to understand their relationship to quantitative measures of postural instability and gait dysfunction. As such, the project can be classified as basic physiologic research. The protocol is not designed to determine if measures of corticocortical or corticofugal excitability can be used as a biomarker to predict disease progression.
Conditions: Parkinson Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Participants with Parkinson's disease
- Diagnosis of idiopathic PD or dystonia as determined by a movement disorders neurologist in accordance with the UK Society Brain Bank diagnostic criteria.
- Age 45-80 years.
- Able to ambulate independently without the use of an assistive device (e.g. cane) for 50 meters.
Healthy Older Adults (Control participants)
- Age 45-80 years (this group will be age and sex-matched to the PD group)
- Able to ambulate independently without the use of an assistive device (cane or walker)
Healthy Young Adults
- Age 21-44 years (this group will be age and sex-matched to the PD group)
- Able to ambulate independently without the use of an assistive device (cane or walker)
Exclusion Criteria
- Subjects who describe a history of a frequent vasovagal syncope (fainting) in response to blood, emotional stress, or sensory triggers.
- Subjects who are on anti-coagulant medications.
- Any musculoskeletal disorder that affects the ability to stand.
- History of seizures, epilepsy, stroke, multiple sclerosis, or traumatic brain injury.
- Intracranial metallic or magnetic devices.
- Pacemaker or any implanted device.
- History of surgery on blood vessels, brain or heart.
- Unexplained, recurring headaches or concussion within the last six months.
- Moderate to severe hearing impairment.
- Subjects who are pregnant.
- Dementia diagnosis
- Other significant neurological disorders that may affect participation or performance in the study
- Implanted deep brain stimulator or other neurosurgeries to treat PD.
Recruiting US locations
University of Minnesota
Minneapolis, MN 55455
Study contacts (from the official record)
- Joshua De Kam · 612-626-8052 · jadekam@umn.edu
Similar studies in Minnesota
All neurology studies in Minnesota →- RecruitingHealthy volunteersPhase 1
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
Alcamena Stem Cell Therapeutics
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Microelectrode Recordings From the Vagus Nerve in Awake Humans
University of Minnesota
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18–40
- RecruitingHealthy volunteersEarly Phase 1
Stimulating After Recovery From Traumatic Brain Injury
University of Minnesota
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Rochester, MN + 9 other US sites
- Eligibility basics
- Ages 6 mo–17